FLUOSPHERA
LIVE

Serial Number

79361288

Owner

FluoSphera SA

Attorney

Douglas R. Wolf

Filing Date

Jun 13, 2022

Add to watchlist:

No watchlists yet
View on USPTO

FLUOSPHERA Trademark

Serial Number: 79361288

FLUOSPHERA is a trademark filed by FluoSphera SA on June 13, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

FluoSphera SA

c/o Fondation Genevoise pour l'Innovation

Entity Type: 99

Trademark Details

Filing Date

June 13, 2022

Registration Date

Not Registered

Goods & Services

Technological services, namely, research and design for medical, biomedical and genetic purposes in the pharmaceutical field; technological services, namely, industrial analysis and research in the field of biotechnology; medical research and development in the pharmaceutical field; research and development in the field of biotechnology; research in the fields of biology; research in the field of biochemistry; development and evaluation of pharmaceutical products; testing of pharmaceutical products; research and development of new products; pharmaceutical research and development services; providing information and data relating to technological research and development in the field of biotechnology; providing research information and results in the field of biotechnology and medicine from an online searchable database; pharmaceutical drug development services; pharmaceutical research and development; development and research of new products for third parties in the fields of pharmaceuticals and biotechnology; research laboratory analysis services in the fields of biotechnology, pharmacotherapy, and pharmaceutical research and development; pharmaceutical and biological development and research services for third parties; evaluation of pharmaceutical product development; laboratory research in the field of medicinal and analytical chemistry, biology, pharmacology and toxicology; none of the foregoing relating to latex microspheres

Pharmaceutical and veterinary products for the treatment of liver diseases and disorders, endocrinological diseases and disorders, cardiovascular diseases and disorders, and cancer; diagnostic products for medical use, namely, medical diagnostic reagents and assays for testing of body fluids, medical diagnostic reagents, diagnostic preparations for medical use; pharmaceutical healthcare preparations for the treatment of liver diseases and disorders, endocrinological diseases and disorders, cardiovascular diseases and disorders, and cancer; medicinal preparations and substances for the treatment of liver diseases and disorders, endocrinological diseases and disorders, cardiovascular diseases and disorders, and cancer; biochemical preparations for medical or veterinary use for the treatment of liver diseases and disorders, endocrinological diseases and disorders, cardiovascular diseases and disorders, and cancer; biological and chemical reagents for medical or veterinary use; biological and chemical preparations for medical use for the treatment of liver diseases and disorders, endocrinological diseases and disorders, cardiovascular diseases and disorders, and cancer; biotechnological preparations for medical use, namely, for the treatment of liver diseases and disorders, endocrinological diseases and disorders, cardiovascular diseases and disorders, and cancer; biotechnological products for medical use, namely, medical preparations for the treatment of liver diseases and disorders, endocrinological diseases and disorders, cardiovascular diseases and disorders, and cancer; biological tissue cultures other than for medical or veterinary use; none of the foregoing relating to latex microspheres

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
May 18, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 18, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 18, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 17, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 17, 2025 GNRT
NON-FINAL ACTION WRITTEN
Nov 17, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 29, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 29, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 29, 2025 TROA
NOTICE OF REVIVAL - E-MAILED
Sep 29, 2025 NREV
PETITION TO REVIVE-GRANTED
Sep 29, 2025 PETG
TEAS PETITION TO REVIVE RECEIVED
Sep 29, 2025 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jul 29, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 29, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 14, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jan 14, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jan 14, 2025 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 16, 2024 RCCK
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 17, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 29, 2024 OPNS
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 15, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 15, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jan 15, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 7, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 6, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 6, 2023 TROA
REFUSAL PROCESSED BY IB
Jun 26, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 6, 2023 RFCS
ATTORNEY REVIEW COMPLETED
Jun 6, 2023 ATRV
ATTORNEY REVIEW COMPLETED
Jun 6, 2023 ATRV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Jun 6, 2023 CREV
REFUSAL PROCESSED BY MPU
Jun 6, 2023 RFRR
CORRECTION TRANSACTION RECEIVED FROM IB
Jun 5, 2023 CRCV
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 8, 2023 RFCR
NON-FINAL ACTION WRITTEN
Apr 7, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 26, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 7, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 3, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 2, 2023 REPR